Latest California Healthline Stories
Montana Med School Clash Revives For-Profit Vs. Nonprofit Flap
Two medical schools vie to open in Montana, highlighting the rapid spread of for-profit schools and their previously tarnished business model.
Analysis: Mounting Pressure on China About Covid ‘Lab Leak’ Could Backfire
Where the coronavirus originated remains a mystery and the Chinese are bucking demands to let investigators see more.
FDA Weighs Approval of a Lucrative Alzheimer’s Drug, but Benefits Are Iffy
The agency is to decide by June 7 whether to greenlight Biogen’s drug aducanumab, despite a near-unanimous rejection of the product by an FDA advisory committee of outside experts in November. Some scientists at the agency have endorsed the drug, though.
KHN’s ‘What the Health?’: The Drug Price Dilemma
Republicans, Democrats and the public at large agree that prices for prescription drugs are too high. But no one seems to know how to fix it. Vanderbilt University drug price researcher Stacie Dusetzina explains the basics of why drugs cost so much and why it’s hard to do something about it. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the prospects for policy changes.
Newsom Wants to Spend Millions on the Health of Low-Income Mothers and Their Babies
Democratic legislators back measures that would end the “pink tax” on diapers and menstrual products, provide mental health support, and pilot a guaranteed-income program.
Expanding Insurance Coverage Is Top Priority for New Medicare-Medicaid Chief
Chiquita Brooks-LaSure, the new head of the Centers for Medicare & Medicaid Services, said the administration will focus on getting more people insured and is interested in finding a way to alleviate the gap keeping low-income families in states that haven’t expanded Medicaid from enrolling in Affordable Care Act health plans.
The ‘Grief Pandemic’ Will Torment Americans for Years
More than 5 million Americans lost a loved one to covid, and the ripple effects could lead to serious illness down the road.
The number of Americans 65 and older is expected to nearly double in the next 40 years. Finding a way to provide and pay for the long-term health services they need won’t be easy.
Behind The Byline: Finding a ‘Superstar’ to Interview
Check out KHN’s video series — Behind The Byline: How the Story Got Made. Come along as journalists and producers offer an insider’s view of health care coverage that does not quit.
KHN’s ‘What the Health?’: The Return of the Public Option
Lawmakers are working on fleshing out the concept of a “public option,” a government-run or heavily regulated insurance plan that would compete with private insurance. But the details are complicated, both substantively and politically. Meanwhile, bioethicists are debating whether the U.S. should be vaccinating low-risk adolescents against covid-19 while high-risk adults in other countries are still waiting. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.